|
pubmed:abstractText |
The state of the art for insect allergy has undergone significant changes over the last two decades. Epinephrine, which is indispensable to treat all but the mildest reactions, is available in portable kits and can be used by the patient when medical help is not readily available. Venom immunotherapy has proven to be safe and effective for those patients who require it, and the concern that lifelong therapy would be necessary is likely to be unwarranted.
|
